superantigen |
interleukin |
As nouns the difference between superantigen and interleukin
is that
superantigen is (biology) an antigen, which has a powerful interaction with t-lymphocytes while
interleukin is (biochemistry) any of a group of cytokine proteins important in the regulation of lymphocyte function.
leukotriene |
interleukin |
In biochemistry terms the difference between leukotriene and interleukin
is that
leukotriene is any of several physiologically active lipids, related to the prostaglandins, that participate in allergic responses while
interleukin is any of a group of cytokine proteins important in the regulation of lymphocyte function.
interleukin |
interferon |
As nouns the difference between interleukin and interferon
is that
interleukin is (biochemistry) any of a group of cytokine proteins important in the regulation of lymphocyte function while
interferon is interferon.
interleukin |
|
interleukin |
interleukine |
As a noun interleukin
is (biochemistry) any of a group of cytokine proteins important in the regulation of lymphocyte function.
As an adjective interleukine is
of or pertaining to interleukin.
interleukin |
fusokine |
As nouns the difference between interleukin and fusokine
is that
interleukin is (biochemistry) any of a group of cytokine proteins important in the regulation of lymphocyte function while
fusokine is (protein) any of a group of interleukins that stimulate the immune system.
interleukin |
mepolizumab |
As nouns the difference between interleukin and mepolizumab
is that
interleukin is (biochemistry) any of a group of cytokine proteins important in the regulation of lymphocyte function while
mepolizumab is a humanized monoclonal antibody that recognizes interleukin-5 and is used to treat certain kinds of asthma and white blood cell diseases.
interleukin |
ustekinumab |
As nouns the difference between interleukin and ustekinumab
is that
interleukin is (biochemistry) any of a group of cytokine proteins important in the regulation of lymphocyte function while
ustekinumab is a human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.
interleukin |
afelimomab |
As nouns the difference between interleukin and afelimomab
is that
interleukin is (biochemistry) any of a group of cytokine proteins important in the regulation of lymphocyte function while
afelimomab is a monoclonal antibody that reduces the concentration of interleukin-6 in patients with sepsis.
interleukin |
canakinumab |
As nouns the difference between interleukin and canakinumab
is that
interleukin is (biochemistry) any of a group of cytokine proteins important in the regulation of lymphocyte function while
canakinumab is a human monoclonal antibody targeted at interleukin-1 beta, intended to treat rheumatoid arthritis.
Pages